Latest Articles

At the heart of any mass spectrometer is the mass analyzer. This component takes the ionized masses and separates them based on their mass-to-charge ratio (m/z). In this article, we consider some of the common types of mass analyzers, their advantages and disadvantages.

In this article, we bring together resources from the across the site on gas chromatography, how it works, its pairing with downstream techniques and what its applications are.

A study investigated whether sunlight might affect COVID-19 mortality, using a study sample incorporating several different countries: The United States, Italy and England. The researchers found that sunnier areas are associated with fewer deaths from COVID-19. Technology Networks spoke with Dr Richard Weller to find out more.

Liquid chromatography (LC) systems are the backbone of pharmaceutical and biopharmaceutical laboratories. However, with increasingly complex samples and efficiency pressures, scientists are seeking more confidence in their results. Can innovative two-dimensional LC (2D-LC) systems provide the answer?

A COVID-19 multiomics data dashboard was generated by authors of a paper recently published in Cell Systems. Ian Miller, research data scientist at the Coon Laboratory, University of Wisconsin-Madison, was a key developer of the platform and walked Technology Networks through some key features of each type of analysis.

In this article, we explore multiomic approaches to COVID-19 research and explore some of the computational and statistical tools being developed to support multiomic analyses.

In a new study published in Cell Metabolism, scientists share their discovery of a novel, non-invasive biomarker test that can be utilized to measure and track the performance of senolytic drugs.

New scientific approaches such as metabolomics and proteomics are shedding light on the causes of AMD and other eye diseases. In this article, we explore how these powerful modern methods are revealing novel biomarkers that are leading to the development of new diagnostic, monitoring and predictive tools, as well as potential treatment options.

The EMBL-EBI announced that it had launched the Genome Integrations with Function and Sequence, or GIFTS, platform in January. This will enable scientists that are using Ensembl and UniProt to access all of the up-to-date genomic and protein data for human and mouse genomes. Technology Networks spoke with the scientists behind GIFTS to learn more.

In this article, we explore the tumor microenvironment (TME), immune infiltration, particularly macrophages, as well as epigenetically-regulated metabolic rewiring.